Yong KL - Search Results

1

Myeloma patients' experiences of a supervised physical activity programme: a qualitative study.

Land J, Hackett J, Sidhu G, Heinrich M, McCourt O, Yong KL, Fisher A, Beeken RJ. Land J, et al. Among authors: yong kl. Support Care Cancer. 2022 Jul;30(7):6273-6286. doi: 10.1007/s00520-022-07062-x. Epub 2022 Apr 25. Support Care Cancer. 2022. PMID: 35467117 Free PMC article.

2

Impact of the treatment-free interval on health-related quality of life in patients with multiple myeloma: a UK cross-sectional survey.

Acaster S, Gaugris S, Velikova G, Yong K, Lloyd AJ. Acaster S, et al. Support Care Cancer. 2013 Feb;21(2):599-607. doi: 10.1007/s00520-012-1548-y. Epub 2012 Aug 12. Support Care Cancer. 2013. PMID: 22886429

3

A mixed exercise training programme is feasible and safe and may improve quality of life and muscle strength in multiple myeloma survivors.

Groeneveldt L, Mein G, Garrod R, Jewell AP, Van Someren K, Stephens R, D'Sa SP, Yong KL. Groeneveldt L, et al. Among authors: yong kl. BMC Cancer. 2013 Jan 24;13:31. doi: 10.1186/1471-2407-13-31. BMC Cancer. 2013. PMID: 23347597 Free PMC article. Clinical Trial.

4

Multiple myeloma and physical activity: a scoping review.

Smith L, McCourt O, Henrich M, Paton B, Yong K, Wardle J, Fisher A. Smith L, et al. BMJ Open. 2015 Nov 27;5(11):e009576. doi: 10.1136/bmjopen-2015-009576. BMJ Open. 2015. PMID: 26614625 Free PMC article. Review.

5

Lifestyle in Multiple Myeloma - a longitudinal cohort study protocol.

Heinrich M, Fisher A, Paton B, McCourt O, Beeken RJ, Hackshaw A, Wardle J, Yong K. Heinrich M, et al. BMC Cancer. 2016 Jul 4;16:387. doi: 10.1186/s12885-016-2407-x. BMC Cancer. 2016. PMID: 27377407 Free PMC article.

6

A phase I/II study of KW-2478, an Hsp90 inhibitor, in combination with bortezomib in patients with relapsed/refractory multiple myeloma.

Cavenagh J, Oakervee H, Baetiong-Caguioa P, Davies F, Gharibo M, Rabin N, Kurman M, Novak B, Shiraishi N, Nakashima D, Akinaga S, Yong K. Cavenagh J, et al. Br J Cancer. 2017 Oct 24;117(9):1295-1302. doi: 10.1038/bjc.2017.302. Epub 2017 Sep 5. Br J Cancer. 2017. PMID: 28873084 Free PMC article. Clinical Trial.

7

PERCEPT myeloma: a protocol for a pilot randomised controlled trial of exercise prehabilitation before and during autologous stem cell transplantation in patients with multiple myeloma.

McCourt O, Fisher A, Ramdharry G, Roberts AL, Land J, Rabin N, Yong K. McCourt O, et al. BMJ Open. 2020 Jan 29;10(1):e033176. doi: 10.1136/bmjopen-2019-033176. BMJ Open. 2020. PMID: 32001493 Free PMC article. Clinical Trial.

8

The adapted Zelen was a feasible design to trial exercise in myeloma survivors.

Land J, McCourt O, Heinrich M, Beeken RJ, Koutoukidis DA, Paton B, Yong K, Hackshaw A, Fisher A. Land J, et al. J Clin Epidemiol. 2020 Sep;125:76-83. doi: 10.1016/j.jclinepi.2020.04.004. Epub 2020 Apr 11. J Clin Epidemiol. 2020. PMID: 32289352 Free PMC article. Clinical Trial.

9

Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design.

Koutoukidis DA, Land J, Hackshaw A, Heinrich M, McCourt O, Beeken RJ, Philpott S, DeSilva D, Rismani A, Rabin N, Popat R, Kyriakou C, Papanikolaou X, Mehta A, Paton B, Fisher A, Yong KL. Koutoukidis DA, et al. Among authors: yong kl. Br J Cancer. 2020 Jul;123(2):187-195. doi: 10.1038/s41416-020-0866-y. Epub 2020 May 21. Br J Cancer. 2020. PMID: 32435057 Free PMC article. Clinical Trial.

10

Multiple myeloma.

van de Donk NWCJ, Pawlyn C, Yong KL. van de Donk NWCJ, et al. Among authors: yong kl. Lancet. 2021 Jan 30;397(10272):410-427. doi: 10.1016/S0140-6736(21)00135-5. Lancet. 2021. PMID: 33516340 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

263 results

Search Page